28 April 2020 in PLOS ONE
Insect bite hypersensitivity (IBH) is a Th-2, IgE-mediated dermatitis of horses caused by bites of insects of the genus Culicoides that has common features with human atopic dermatitis. Together with Th-2 cells, the epithelial barrier plays an important role in development of type I hypersensitivities. In order to elucidate the role of the epithelial barrier and of the skin immune response in IBH we studied the transcriptome of lesional whole skin of IBH-horses (IBH-LE; n = 9) in comparison to non-lesional skin (IBH-NL; n = 8) as well as to skin of healthy control horses (H; n = 9). To study the "baseline state" of the epithelial barrier, we investigated the transcriptome of non-lesional epidermis in IBH-horses (EPI-IBH-NL; n = 10) in comparison with healthy epidermis from controls (EPI-H; n = 9). IBH-LE skin displayed substantial transcriptomic difference compared to H. IBH-LE was characterized by a downregulation of genes involved in tight junction formation, alterations in keratins and substantial immune signature of both Th-1 and Th-2 types with particular upregulation of IL13, as well as involvement of the hypoxic pathway. IBH-NL shared a number of differentially expressed genes (DEGs) with IBH-LE, but was overall more similar to H skin. In the epidermis, genes involved in metabolism of epidermal lipids, pruritus development, as well as IL25, were significantly differentially expressed between EPI-IBH-NL and EPI-H. Taken together, our data suggests an impairment of the epithelial barrier in IBH-affected horses that may act as a predisposing factor for IBH development. Moreover, these new mechanisms could potentially be used as future therapeutic targets. Importantly, many transcriptional features of equine IBH skin are shared with human atopic dermatitis, confirming equine IBH as a natural model of skin allergy.
21 November 2019 in Veterinary Dermatology
Background: Thymic stromal lymphopoietin (TSLP) plays a key role in the development of allergic inflammation. Little is known about possible triggers of equine TSLP expression.Hypothesis/objectives: To investigate TSLP expression in equine insect bite hypersensitivity (IBH) skin lesions. The capacity of TLR 1‐8 ligands (L) and of atopic cytokine milieu as potential triggers of TSLP and of interleukin (IL)‐6 as a downstream effector molecule of TLR signalling, were examined in primary equine keratinocyte cultures.Animals: Lesional skin from IBH‐affected and healthy skin from control‐horses (n = 9 each group) was sampled.Methods and materials: Keratinocyte cultures were established from six healthy horses and stimulated with TLR 1‐8‐L, and with IL‐4 and tumor necrosis factor‐α, to mimic an atopic inflammation cytokine milieu. TSLP and IL‐6 gene expression was assessed by quantitative real‐time PCR.Results: Expression of TSLP was significantly greater in IBH lesions compared to healthy skin. TLR 1‐8‐L significantly upregulated TSLP expression in keratinocytes. The strongest upregulation was induced by TLR 1/2‐L and TLR 3‐L. Combination of atopic cytokine milieu and TLR 1/2‐L or TLR 3‐L further increased TSLP expression. TLR‐L 1‐5 stimulation significantly upregulated IL‐6 expression.Conclusions and clinical importance: The data herein suggest that the upregulation of TSLP expression in lesional skin of IBH‐affected horses might play a role in IBH development. Moreover, TSLP expression is induced by TLR‐L, in particular by TLR 1/2‐L and TLR 3‐L, and is further increased by atopic cytokine milieu, indicating a mechanism for TSLP‐mediated exacerbation of IBH.
18 November 2021 in Veterinary Dermatology
Culicoides hypersensitivity (CH) is a strongly pruritic dermatitis of horses, characterised histologically by mixed perivascular to diffuse cellular infiltrates of mononuclear cells and eosinophils, and caused by helper T cell (Th)2, immunoglobulin (Ig)E‐mediated reactions to antigens present in the saliva of biting Culicoides midges. As treatment of CH is still not satisfactory, a better knowledge of the pathogenesis of CH is needed for the development of new therapeutic modalities. Accordingly, availability of pure Culicoides allergens instead of crude whole body extracts is essential for the improvement of in vitro diagnosis of CH and development of a more effective allergen immunotherapy (AIT). Beside the Th2 cytokines interleukin (IL)‐4 and IL‐13, recent studies have shown the involvement of thymic stromal lymphopoietin, IL‐5 and IL‐31 in the pathogenesis of CH. The importance of IL‐5 and IL‐31 has been confirmed through targeting these cytokines by active immunisation of CH patients, resulting in a significant decrease of CH lesion scores. Thirty Culicoides salivary allergens have been described over the last 10 years and produced as pure recombinant (r‐) proteins. Use of a protein microarray has allowed the identification of the most relevant Culicoides r‐allergens for CH in central and northern Europe. An immunisation protocol has been developed for preventive AIT against CH. Small amounts of r‐Culicoides allergens injected into the submandibular lymph nodes with Alum/MPLA as adjuvants seem to induce a suitable immune response for both preventive and therapeutic AIT. The next years will reveal whether these recent advancements will translate into an improved diagnosis, treatment and prevention of CH.
1 August 2022 in PLOS ONE
Equine insect bite hypersensitivity (IBH) is the most common skin disease affecting horses. It is described as an IgE-mediated, Type I hypersensitivity reaction to salivary gland proteins of Culicoides insects. Together with Th2 cells, epithelial barrier cells play an important role in development of Type I hypersensitivities. In order to elucidate the role of equine keratinocytes in development of IBH, we stimulated keratinocytes derived from IBH-affected (IBH-KER) (n = 9) and healthy horses (H-KER) (n = 9) with Culicoides recombinant allergens and extract, allergic cytokine milieu (ACM) and a Toll like receptor ligand 1/2 (TLR-1/2-L) and investigated their transcriptomes. Stimulation of keratinocytes with Culicoides allergens did not induce transcriptional changes. However, when stimulated with allergic cytokine milieu, their gene expression significantly changed. We found upregulation of genes encoding for CCL5, -11, -20, -27 and interleukins such as IL31. We also found a strong downregulation of genes such as SCEL and KRT16 involved in the formation of epithelial barrier. Following stimulation with TLR-1/2-L, keratinocytes significantly upregulated expression of genes affecting Toll like receptor and NOD-receptor signaling pathway as well as NF-kappa B signaling pathway, among others. The transcriptomes of IBH-KER and H-KER were very similar: without stimulations they only differed in one gene (CTSL); following stimulation with allergic cytokine milieu we found only 23 differentially expressed genes (e.g. CXCL10 and 11) and following stimulation with TLR-1/2-L they only differed by expression of seven genes. Our data suggests that keratinocytes contribute to the innate immune response and are able to elicit responses to different stimuli, possibly playing a role in the pathogenesis of IBH.
3 March 2026 in SSRN Electronic Journal
Several clostridial species can cause severe diseases in humans and animals. Among their most frequent virulence factors are hemolysin β-pore-forming toxins (β-PFTs). These protein toxins are secreted as soluble monomers that oligomerize on host cell membranes to form membrane-inserted β-barrel pores. Recent research on bacterial β-PFTs showed that many, including clostridial PFTs, target their host cells via specific membrane protein receptors. To date, 14 β-PFTs and related homologs have been identified in different Clostridium species, most of which remain uncharacterized. Here we report 11 additional putative β-PFT homologs identified across six Clostridium species through database analyses. We reviewed knowledge from genomic, in vitro and in vivo studies on clostridial β-PFTs, with emphasis on toxin- host cell recognition and the roles in the pathogenesis of diseases.